Items in cart [4] Questions? Call 888-624-8373

PAPERBACK list:$36.00 Web:$32.40 add to cart Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters PDF EXECUTIVE SUMMARY PDF Report Brief Display this book on your site! Related Titles The Learning Healthcare System: Workshop Summary (IOM Roundtable on Evidence-Based Medicine) From Cancer Patient to Cancer Survivor: Lost in Transition Other Related Titles Initial National Priorities for Comparative Effectiveness Research (2009) Board on Health Care Services (HCS) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 167   E-mail  Facebook  Digg  Stumble  Twitter More Page 167 Front Matter (R1-R24) Summary (1-20) 1 Introduction (21-28) 2 What Is Comparative Effectiveness Research? (29-60) 3 Obtaining Input to Identify National Priorities for Comparative Effectiveness Research (61-76) 4 The Criteria and Process for Setting Priorities (77-96) 5 Priorities for Study (97-138) 6 Essential Priorities for a Robust CER Enterprise (139-166) Appendix A: Public Meeting Agenda - March 20, 2009 (167-170) Appendix B: Stakeholder Questionnaire (171-188) Appendix C: Data Tables: Burden of Disease and Variation of Care (189-198) Appendix D: Cardiovascular and Peripheral Vascular Cover Sheet (199-202) Appendix E: Definitions of Medical Terminology in CER Priority List (203-212) Appendix F: Committee Biographies (213-228)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 167
Appendix A Public Meeting Agenda— March 20, 2009 COMMITTEE ON COMPARATIvE EFFECTIvENESS RESEARCH PRIORITIzATION PubLIC AGENDA—FRIDAy, MARCH 20, 2009 FRIDAy, MARCH 20 — OPEN SESSION Stakeholder’s Presentations — Auditorium 8:30am Welcome to Public Session (Dr. Sox) • Mechanisms of announcement (email, website) • Mechanisms of input (meeting and call-in presentations, web submissions) 9:00am Invited presentations from stakeholders • Myrl Weinberg, National Health Council • Nancy Nielsen, American Medical Association • Carmella Bocchino, America’s Health Insurance Plans • Ted Buckley, Biotechnology Industry Organization • Mary Jean Schumann, American Nurses Association • William Vaughan, Consumers Union • Ted Epperly, American Academy of Family Physicians • Randy Burkholder, Pharmaceutical Research and Manufacturers of America Question and Answer Session 

OCR for page 168
 INITIAL NATIONAL PRIORITIES FOR CER 10:00am • Naomi Aronson, Blue Cross/Blue Shield Association • Mohammad Akhter, National Medical Association • Dorothy Jeffress, Center for Advancement of Health • Robert Hall, American Academy of Pediatrics • Teresa Lee, Advanced Medical Technology Association • Antonio C. Wolff, American Society of Clinical Oncology • Jack Lewin, American College of Cardiology • Harold Miller, Network for Regional Healthcare Improvement Question and Answer Session 11:00am • Bryan Luce, United BioSource Corporation • Leah Hole-Curry, WA State Health Care Authority • Erick Turner, Oregon health and Science University and Portland VA Medical • Robert Harrison, California Dept of Public Health • Gary Puckrein, National Minority Quality Forum • Marilyn Dix Smith, International Society for Pharmacoeconomics & Outcomes Research • Frederick Grover, Society of Thoracic Surgeons • Douglas Hadley, CIGNA • Adolph Falcon, National Alliance for Hispanic Health • Roger Williams, United States Pharmacopeia Question and Answer Session 12:00pm Lunch Break 1:00pm • Nada Stotland, American Psychiatric Association • Ruth Lubic, Developing Families Center • William Weintraub, American Heart Association • Eugene Rich, Association of American Medical Colleges • Merrill Goozner, Center for Science in the Public Interest • Jeff Allen, Friends of Cancer Research • Les Paul, National Pharmaceutical Council • Steven Bailey, Society for Cardiovascular Angiography and Interventions Question and Answer Session 2:00pm • Clifford Goodman, The Lewin Group • Amy Abernethy, Duke University Medical Center • Katie Orrico, American Association of Neurological Surgeons

OCR for page 169
 APPENDIX A • Christopher Fox, American Association for Dental Research • Amy Miller, Personalized Medicine Coalition • Douglas Peddicord, Association of Clinical Research Organizations • Patrick O’Connor, HealthPartners Research Foundation • Janet Marchibroda, eHealth Initiative Question and Answer Session 3:00pm • James Bray, American Psychological Association • C. Edwin Webb, American College of Clinical Pharmacy • Harrison Spencer, Association of Schools of Public Health • Andrew Sperling, National Alliance on Mental Illness • John Brooks, University of Iowa • Marty Makary, American College of Surgeons • Perry D. Cohen, Parkinson Pipeline Project • Morgan Downey, Health Care Consultancy • Dennis Hart, Focus On Therapeutic Outcomes, Inc. • Eunince K. M. Ernst, Frontier School of Midwifery & Family Nursing • Carolyn Curtis • Patrick O’Connor, American College of Occupational and Environmental Medicine Question and Answer Session 3:50pm Concluding remarks (Dr. Sox) 4:00pm Adjourn

OCR for page 170